Dosing & Side Effects
Titration schedules, common side effects, muscle loss and what happens after stopping.
5-Amino-1MQ side effects, risks and timelines: what the evidence actually covers
What is known about 5-Amino-1MQ side effects and risks, from the mouse studies that recorded no observable adverse effects to the off-target MAO-A finding and poor oral absorption in mice, plus how long it took to work in animals and what 'before and after' results really measure.
GLP-1 side effects and how to manage them
A clear, source-backed guide to GLP-1 side effects in 2026, the common gut symptoms, why slow titration reduces them, the serious labeled warnings, and the real-world effects people talk about, plus how a provider keeps them manageable.
Retatrutide side effects: trial data vs what people report online
What Eli Lilly's retatrutide trials recorded as side effects (nausea, diarrhea, vomiting, skin sensitivity, heart rate) set beside the hair loss and fatigue questions people raise online, with the evidence level stated for each and a comparison with Wegovy and Zepbound.
GLP-1 dosing and titration explained: why you start low and step up
A plain-English guide to how GLP-1 dosing and titration works: why doses start low and step up over weeks, and the FDA-label escalation schedules for Wegovy and Zepbound.
GLP-1 and muscle loss: how to keep lean mass while losing weight
Some of the weight you lose on a GLP-1 is lean tissue, but most of it is fat, and the loss looks similar to other kinds of weight loss. Here is what the body-composition evidence shows and how protein and resistance training protect muscle.
What happens when you stop a GLP-1?
What the randomized withdrawal trials of semaglutide and tirzepatide show about weight regain after you stop a GLP-1, why appetite comes back, whether staying on the medication keeps the weight off, and what maintenance dosing can and cannot promise.